176 related articles for article (PubMed ID: 16850369)
1. Immunosuppression: today, tomorrow, and withdrawal.
Hirose R; Vincenti F
Semin Liver Dis; 2006 Aug; 26(3):201-10. PubMed ID: 16850369
[TBL] [Abstract][Full Text] [Related]
2. Current concepts and perspectives of immunosuppression in organ transplantation.
Scherer MN; Banas B; Mantouvalou K; Schnitzbauer A; Obed A; Krämer BK; Schlitt HJ
Langenbecks Arch Surg; 2007 Sep; 392(5):511-23. PubMed ID: 17450373
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppressive activity of serum taken from a liver transplant recipient after withdrawal of immunosuppressants.
Hsu LW; Goto S; Nakano T; Lai CY; Lin YC; Kao YH; Chen SH; Cheng YF; Jawan B; Chiu KW; Chen CL
Transpl Immunol; 2007 Feb; 17(2):137-46. PubMed ID: 17306745
[TBL] [Abstract][Full Text] [Related]
4. New developments in clinical immunosuppression.
Watschinger B; Wenter C; Demetriou D
Kidney Blood Press Res; 2000; 23(3-5):191-2. PubMed ID: 11031719
[TBL] [Abstract][Full Text] [Related]
5. [Advances in immunossuppression in liver transplantation].
Olivera-Martínez MA
Rev Invest Clin; 2005; 57(2):237-43. PubMed ID: 16524064
[TBL] [Abstract][Full Text] [Related]
6. Review of transplantation--1999.
Hirose R; Vincenti F
Clin Transpl; 1999; ():295-315. PubMed ID: 11038649
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppression for liver transplantation.
Geissler EK; Schlitt HJ
Gut; 2009 Mar; 58(3):452-63. PubMed ID: 19052024
[TBL] [Abstract][Full Text] [Related]
8. Belatacept: a novel biologic for maintenance immunosuppression after renal transplantation.
Martin ST; Tichy EM; Gabardi S
Pharmacotherapy; 2011 Apr; 31(4):394-407. PubMed ID: 21449628
[TBL] [Abstract][Full Text] [Related]
9. New aspect of immunosuppressive treatment in liver transplantation. How could you induce tolerance in liver transplantation?
Beaudreuil S; Samuel D; Rouas-Freiss N; Durrbach A
Transpl Immunol; 2007 Feb; 17(2):98-107. PubMed ID: 17306740
[TBL] [Abstract][Full Text] [Related]
10. Biological agents in kidney transplantation: belatacept is entering the field.
Wéclawiak H; Kamar N; Ould-Mohamed A; Cardeau-Desangles I; Rostaing L
Expert Opin Biol Ther; 2010 Oct; 10(10):1501-8. PubMed ID: 20726688
[TBL] [Abstract][Full Text] [Related]
11. Evolving trends in induction therapy.
Arias M; Campistol JM; Vincenti F
Transplant Rev (Orlando); 2009 Apr; 23(2):94-102. PubMed ID: 19298940
[TBL] [Abstract][Full Text] [Related]
12. Induction therapy: why, when, and which agent?
Krischock L; Marks SD
Pediatr Transplant; 2010 May; 14(3):298-313. PubMed ID: 20345609
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppression in liver transplantation.
Everson GT; Trotter JF; Kugelmas M; Forman L
Minerva Chir; 2003 Oct; 58(5):725-40. PubMed ID: 14603151
[TBL] [Abstract][Full Text] [Related]
14. What do we know about the clinical impact of complete withdrawal of immunosuppression in liver transplantation?
Pons JA; Revilla Nuin B; Ramírez P; Baroja Mazo A; Martínez Alarcón L; Robles R; Sánchez Bueno F; Rios A; Cascales Campos P; Parrilla P
Transplant Proc; 2012; 44(6):1530-2. PubMed ID: 22841204
[TBL] [Abstract][Full Text] [Related]
15. Steroid and calcineurin inhibitor-sparing protocols in kidney transplantation.
Helal I; Chan L
Transplant Proc; 2011 Mar; 43(2):472-7. PubMed ID: 21440737
[TBL] [Abstract][Full Text] [Related]
16. Evolving immunosuppressive regimens for lung transplant recipients.
Meyer NJ; Bhorade SM
Semin Respir Crit Care Med; 2006 Oct; 27(5):470-9. PubMed ID: 17072795
[TBL] [Abstract][Full Text] [Related]
17. HLA mismatches remain risk factors for acute kidney allograft rejection in patients receiving quadruple immunosuppression with anti-interleukin-2 receptor antibodies.
Wissing KM; Fomegné G; Broeders N; Ghisdal L; Hoang AD; Mikhalski D; Donckier V; Vereerstraeten P; Abramowicz D
Transplantation; 2008 Feb; 85(3):411-6. PubMed ID: 18322434
[TBL] [Abstract][Full Text] [Related]
18. Novel immunosuppression: small molecules and biologics.
Yabu JM; Vincenti F
Semin Nephrol; 2007 Jul; 27(4):479-86. PubMed ID: 17616278
[TBL] [Abstract][Full Text] [Related]
19. Belatacept: a new biologic and its role in kidney transplantation.
Su VC; Harrison J; Rogers C; Ensom MH
Ann Pharmacother; 2012 Jan; 46(1):57-67. PubMed ID: 22215686
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive agents in organ transplantation: past, present, and future.
Hong JC; Kahan BD
Semin Nephrol; 2000 Mar; 20(2):108-25. PubMed ID: 10746855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
